A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19 - npj Digital Medicine

Australia News News

A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19 - npj Digital Medicine
Australia Latest News,Australia Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

Smartwatches can help guide COVID-19 testing NaturePortfolio

). The superior performance of the ITA model using RHR-only features over the ITA model using steps-only and the ITA model using both steps and RHR features may be attributed to the nonspecific nature of the steps features, which can experience changes unrelated to COVID-19 .

We further explored how the ITA model performs in symptomatic versus asymptomatic COVID-19-positive individuals in each cohort. We considered participants to be symptomatic who reported any symptoms in the detection period or on the diagnostic test date.

In this work, we demonstrated that wearable device data can be used to strategically target the allocation of diagnostic tests to where they are most useful. This approach not only increases testing efficiency and allocation but also reduces the costs and supply chain burden of surveillance testing which is an ongoing challenge.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia UdeGuanajuato pulmonary radiology SARSCoV2 COVID19 coronavirus covid pneumonia
Read more »

Effect of COVID-19 mRNA vaccination on COVID-19 severity during Omicron BA.4 and BA.5 predominance periodsEffect of COVID-19 mRNA vaccination on COVID-19 severity during Omicron BA.4 and BA.5 predominance periodsIn a new study, researchers estimated the association of first-generation messenger ribonucleic acid (mRNA) vaccines (BNT162b2, mRNA-1273) with coronavirus disease 2019 (COVID-19)-related medical encounters.
Read more »

Reduced expression of interleukin 8 and interferon-gamma cytokines identified in long COVIDReduced expression of interleukin 8 and interferon-gamma cytokines identified in long COVIDIn a new study, researchers compared serum cytokine expression among healthy individuals and those with PASC [post-acute sequelae of coronavirus disease 2019 (COVID-19)].
Read more »

What is the impact of pre-COVID vaccination on long COVID?What is the impact of pre-COVID vaccination on long COVID?What is the impact of pre-COVID vaccination on long COVID? medrxivpreprint CUAnschutz LongCOVID COVID19 SARSCoV2 Vaccination Vaccine
Read more »

The association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case reportThe association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case reportThe association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case report mRNA vaccine vaccination COVID19 coronavirus covid
Read more »



Render Time: 2025-04-03 23:55:49